Usana Health Sciences (USNA) Depreciation & Amortization (CF) (2016 - 2026)
Usana Health Sciences has reported Depreciation & Amortization (CF) over the past 16 years, most recently at $8.3 million for Q2 2026.
- Quarterly Depreciation & Amortization (CF) fell 0.74% to $8.3 million in Q2 2026 from the year-ago period, while the trailing twelve-month figure was $32.5 million through Apr 2026, up 64.81% year-over-year, with the annual reading at $32.6 million for FY2026, 123.96% up from the prior year.
- Depreciation & Amortization (CF) was $8.3 million for Q2 2026 at Usana Health Sciences, down from $8.6 million in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $8.6 million in Q1 2026 and troughed at $2.5 million in Q1 2022.
- The 5-year median for Depreciation & Amortization (CF) is $3.4 million (2022), against an average of $4.7 million.
- Year-over-year, Depreciation & Amortization (CF) dropped 11.54% in 2023 and then skyrocketed 164.06% in 2025.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $3.3 million in 2022, then fell by 11.54% to $2.9 million in 2023, then soared by 37.33% to $4.0 million in 2024, then soared by 98.02% to $7.9 million in 2025, then increased by 4.52% to $8.3 million in 2026.
- Per Business Quant, the three most recent readings for USNA's Depreciation & Amortization (CF) are $8.3 million (Q2 2026), $8.6 million (Q1 2026), and $7.9 million (Q3 2025).